Gainers
-
Moleculin Biotech Inc (NASDAQ: MBRX) shares rose
40.7 percent to $3.39 in the pre-market trading session after the company disclosed that it has received the FDA approval for
its Annamycin IND.
-
Ascena Retail Group Inc (NASDAQ: ASNA) rose 16.6
percent to $2.53 in pre-market trading after the company posted stronger-than-expected results for its fourth quarter.
- Chromadex Corp (NASDAQ: CDXC) rose 16 percent to $5.00 in pre-market trading after the company reported top-line
results from its second human clinical trial.
-
Greenhill & Co., Inc. (NYSE: GHL) shares rose 13.9
percent to $16.40 in pre-market trading after the company disclosed outline of recap plan and share repurchase.
-
Social Reality Inc (NASDAQ: SRAX) shares rose
10.2 percent to $2.70 in pre-market trading after surging 50.31 percent on Monday.
-
Vascular Biogenics Ltd (NASDAQ: VBLT) rose 9.3
percent to $7.10 in pre-market trading after gaining 4.84 percent on Monday.
-
Apollo Endosurgery Inc (NASDAQ: APEN) rose 7.7
percent to $4.90 in pre-market trading after falling 0.87 percent on Monday.
-
ProQR Therapeutics NV (NASDAQ: PRQR) rose 7
percent to $6.90 in pre-market trading after the company disclosed 'positive' top-line data from Phase 1b study of QR-010.
-
Izea Inc (NASDAQ: IZEA) rose 6.8 percent to $5.18
in pre-market trading after jumping 51.56 percent on Monday.
-
Akebia Therapeutics Inc (NASDAQ: AKBA) rose 5.1
percent to $18.80 in pre-market trading. Akebia Therapeutics disclosed that statistically significant improvements in the
primary endpoint were made in its Phase 2 study of Vadadustat.
-
Helios and Matheson Analytics Inc (NASDAQ: HMNY)
rose 4.6 percent to $8.68 in pre-market trading after surging 19.08 percent on Monday.
-
Red Hat Inc (NYSE: RHT) rose 4.3 percent to $110.26
in pre-market trading after the company reported better-than-expected results for its second quarter and raised its guidance
for the year.
-
Kitov Pharmaceuticals Holdings Ltd (ADR) (NASDAQ: KTOV) shares rose 3.7 percent to $2.22 in pre-market trading after climbing
12.63 percent on Monday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
-
Axovant Sciences Ltd (NASDAQ: AXON) shares fell
69.7 percent to $7.36 after the company disclosed that Phase 3 MINDSET clinical trial did not meet its co-primary efficacy
endpoints.
-
Genocea Biosciences Inc (NASDAQ: GNCA) fell 55.2
percent to $2.39 in pre-market trading after the company reported strategic shift to immuno-oncology and development of
neoantigen cancer vaccines. The company also announced plans to explore strategic alternatives for GEN-003 and lower staff by
40 percent.
-
Kadmon Holdings Inc (NASDAQ: KDMN) fell 21.1
percent to $2.99 in pre-market trading as the company reported mixed shelf offering.
-
QEP Resources Inc (NYSE: QEP) shares fell 7.1
percent to $8.25 in pre-market trading after the company reported the closing of Pinedale asset sale and lowered its FY17
production outlook.
-
TherapeuticsMD Inc (NYSE: TXMD) shares fell 6.8
percent to $5.65 in pre-market trading. TherapeuticsMD priced its 12.4 million share offering at $5.65 per share.
-
Sabra Health Care REIT Inc (NASDAQ: SBRA) fell
6.1 percent to $20.98 in pre-market trading. Sabra Health Care REIT priced an underwritten public offering of 16,000,000 shares
at $21.00 per share.
-
Aradigm Corporation (NASDAQ: ARDM) shares fell
5.1 percent to $3.19 in pre-market trading after climbing 32.81 percent on Monday.
-
Cheesecake Factory Inc (NASDAQ: CAKE) fell 4.6
percent to $39.70 in pre-market trading. Wedbush downgraded Cheesecake Factory from Outperform to Neutral.
-
Darden Restaurants, Inc. (NYSE: DRI) shares fell 3.8
percent to $80.02 in pre-market trading. Darden posted in-line quarterly earnings.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.